The anaesthetic management of an elderly patient with severely impaired left ventricular function undergoing thoracotomy and lobectomy is described. Total intravenous anaesthesia (TIVA) with remifentanil and targetcontrolled infusion of propofol titrated according to the bispectral index (BIS) was used, with thoracic epidural anaesthesia commenced at the end of surgery providing postoperative analgesia. Avoidance of intraoperative epidural local anaesthetics and careful titration and dose reduction of propofol using the BIS was associated with excellent haemodynamic stability. The rapid offset of action of remifentanil and low-dose propofol facilitated early recovery and tracheal extubation. The BIS was a valuable monitor in optimal titration of TIVA.
The bispectral index (BIS, Aspect Medical Systems Inc, MA) is a computer-processed EEG on a scale from 0 (=no EEG activity) to 100 (=fully awake) 1 . The BIS monitor is simple to use (only requiring application of disposable electrodes on specified positions on the head) and recent studies have found that BIS monitoring can reduce anaesthetic drug administration and recovery times 2 . This approach may reduce adverse effects of anaesthetic drugs in patients with severe cardiorespiratory disease. The considerable challenge of providing safe anaesthesia for patients with severe left ventricular dysfunction undergoing major surgery has in the past been met by use of high-dose opioid techniques. While reducing haemodynamic instability 3 , opioids have mandated prolonged periods of postoperative ventilation. We describe an alternative technique using propofol and remifentanil total intravenous anaesthesia titrated according to the BIS in combination with postoperative thoracic epidural analgesia.
CASE REPORT
A 78-year-old, 66 kg man presented for thoracotomy and right upper lobectomy for squamous cell carcinoma. His past medical history included chronic obstructive airways disease, valvular and ischaemic heart disease. Six years previously he had undergone a mechanical aortic valve replacement for aortic incompetence, and coronary artery bypass grafting following a large anterolateral myocardial infarction. At that time he was found to have a dilated cardiomyopathy with severely impaired left ventricular (LV) function. His recovery was complicated by cardiac and respiratory failure requiring prolonged mechanical ventilation. He required frequent hospital admission for treatment of LV failure over the following years.
During a recent admission with acute pulmonary oedema, a chest X-ray had shown a peripherally based right upper lobe lesion which subsequent CT-guided aspiration cytology confirmed to be a squamous cell carcinoma. Treatment of his heart failure led to an improvement in exercise capacity such that he could tolerate a minimal level of exercise. Further investigations at this time included a CT of the chest which confirmed a 4.5 cm right upper lobe lesion with no evidence of mediastinal lymphadenopathy. Exercise thallium 201 myocardial study showed no reversible ischaemia but evidence of a large completed anterolateral infarct and significantly impaired LV function. Transthoracic echocardiography confirmed a dilated LV with ejection fraction of 25%, normal prosthetic aortic valve function and mild mitral regurgitation. Pulmonary function tests showed an FEV 1 of 2.24l (92% predicted), FVC 3.37 l (83% predicted), and FEV 1 / FVC 66.5%.
The high operative risk for this patient and the possibility of prolonged intensive care unit (ICU) stay potentially complicated by cardiac and/or respiratory failure was considered. However as the patient at this time was in compensated cardiac failure and his condition was unlikely to be further improved preoperatively, a decision was made to proceed with surgery following a detailed discussion with the patient of the likely risks and benefits involved.
Warfarin was discontinued preoperatively and a heparin infusion substituted. Other medications included perindopril 4 mg/day, digoxin 0.125 mg/day, frusemide 120 mg bd and glyceryl trinitrate patch 10 mg 18 hourly. Full blood count and urea and electrolytes were normal. On the morning of surgery the International Normalized Ratio (INR) was 1.3 and activated partial thromboplastin time was 35 seconds (heparin infusion discontinued three hours previously).
Prior to induction of anaesthesia a thoracic epidural catheter was inserted at the T6-7 interspace, and invasive monitoring was established with a left radial arterial line and a pulmonary artery catheter inserted via the right internal jugular vein. Midazolam 2 mg (in 0.5 mg boluses) was given intravenously during these procedures. Monitoring also included five-lead ECG with ST segment analysis, pulse oximetry and capnography.
BIS monitoring (Aspect Medical Systems Inc, model 1050) was established prior to induction of anaesthesia. Anaesthesia was induced slowly with a target-controlled infusion (TCI) of propofol, commencing at 0.7 µg/ml (approximate induction dose of 40 mg over five minutes), and a remifentanil infusion (1 µg/kg bolus followed by 0.4 µg/kg/min). There was no autonomic response or elevation of BIS to laryngoscopy or intubation.
We aimed for a BIS level of 40 to 60 during surgery, titrating the propofol TCI accordingly. Thus, the TCI setting was increased by 0.4 to 0.6 µg/ml each four minutes to 2.8 µg/ml. Rocuronium 50 mg provided muscle relaxation. A 39 FG left double-lumen endobronchial tube was inserted and intermittent positive pressure ventilation (IPPV) with a pressure controlled mode was used. The patient was ventilated with 100% oxygen until after lung resection and reestablishment of two-lung ventilation; nitrous oxide was not used. Normothermia was maintained using a lower body forced air warming device and warmed IV fluids. Anaesthesia was maintained with propofol TCI 2.0-2.4 µg/ml (approximate infusion rate 3 mg/kg/h), and remifentanil 0.4 µg/kg/min. There was no autonomic response or elevation of BIS to surgical stimulation throughout the procedure.
Arterial blood pressure decreased slightly after induction and during one-lung ventilation but was easily maintained with metaraminol 0.25 to 0.5 mg boluses (total 2.5 mg). Cardiac index (1.9 to 2.2 l/min/m 2 ), measured by thermodilution in triplicate, remained similar to the pre-induction value (2.1 l/min/m 2 ) throughout the procedure. Mean pulmonary artery pressure (22 to 26 mmHg) also remained stable. The BIS ranged between 40 and 56 throughout.
The procedure included a lateral thoracotomy incision at the sixth intercostal space, lasted 150 minutes and blood loss was minimal (~200ml). At the commencement of chest closure bupivacaine 0.25% was given in incremental boluses through the epidural catheter to a total dose of 12 ml and the remifentanil infusion was discontinued. Neuromuscular blockade was reversed with neostigmine and glycopyrrolate. The patient was spontaneously ventilating with adequate tidal volumes and obeying commands approximately 10 minutes after completion of surgery and was extubated in the operating room. Oxygen was administered by facemask at 6 l/min, a continuous epidural infusion of bupivacaine 1.25 mg/ml and fentanyl 2 µg/ml was commenced at 8 ml/hr and the patient was transferred to the ICU for continued respiratory and haemodynamic monitoring.
At postoperative review on the first and second day the patient had no recall of intraoperative events. He had good analgesia on coughing and deep inspiration with the epidural infusion plus intermittent doses of tramadol for breakthrough pain. Arterial blood gases on day 2 with an FiO 2 of 0.6 were P a O 2 117 mmHg, P a CO 2 52 mmHg and pH 7.30.
On the third postoperative day the patient developed atrial fibrillation with a ventricular rate of 160 to 170/min which rapidly progressed to a pulseless ventricular tachycardia. Resuscitation with DC cardioversion, lignocaine 100 mg and adrenaline (total 2 mg) was successful. He was intubated, IPPV commenced and an amiodarone infusion was given. On the fifth postoperative day the patient was in sinus rhythm, haemodynamically stable, alert and spontaneously ventilating and the trachea was extubated. There was no evidence of acute myocardial infarction. He was discharged from hospital three weeks after surgery and at three-month follow-up he had returned to his preoperative functional capacity and continues to live independently at home.
DISCUSSION
Anaesthetic management of patients with severely impaired ventricular function undergoing major noncardiac surgery present a significant challenge. The ideal anaesthetic in this group of patients would provide intraoperative haemodynamic stability, allow rapid emergence to facilitate early tracheal extubation if warranted and provide optimal postoperative analgesia.
To achieve these goals, we used the rapidly titratable potent opioid remifentanil in combination with low-dose propofol TCI. BIS monitoring allowed maximal use of the propofol dose-sparing effect of remifentanil 4 and thereby improved haemodynamic stability while minimizing the risk of awareness. Thoracic epidural anaesthesia introduced at the end of surgery provided excellent postoperative analgesia which facilitated improved postoperative pulmonary function 5 .
The effects of epidural anaesthesia on overall perioperative morbidity and mortality in high risk surgical patients remains controversial. Some studies have demonstrated a significant reduction in cardiovascular failure and infectious complications 6 and others have shown reduced postoperative pulmonary morbidity 5 with epidural anaesthesia. Many studies have shown a significant reduction in the neurohumoral stress response to surgery [6] [7] [8] and reduced myocardial oxygen consumption 9, 10 . Earlier tracheal extubation 11 and improved postoperative pulmonary function 5, 11 have also been reported. These and other potentially beneficial effects on outcome have yet to be evaluated in a large randomized controlled trial. However intraoperative use of epidural local anaesthetics in combination with general anaesthesia may lead to increased haemodynamic instability 13 and persisting hypotension often leads to the depth of anaesthesia being reduced, with an increased risk of awareness. Therefore in this patient we chose to introduce thoracic epidural anaesthesia at the end of the procedure, having inserted the catheter prior to induction.
Much of the experience in anaesthetic management of patients with severely impaired ventricular function has come from cardiac anaesthesia where high-dose opioid techniques have been widely used. High-dose opioids can minimize haemodynamic instability, but may mandate prolonged periods of postoperative ventilation. Recent interest in earlier extubation after cardiac surgery has focused attention on the potential benefits of propofol-opioid based techniques 14 . Despite initial concerns regarding vasodilating and myocardial depressant effects, use of propofol anaesthesia in patients with normal left ventricular function has not caused significant myocardial depression. More recently propofol anaesthesia in patients with impaired left ventricular function has been shown to be safe 14, 15 , and to facilitate earlier tracheal extubation without adverse haemodynamic events 14, 15 .
The potent opioid effect of remifentanil reduces haemodynamic responses to stressful surgical stimuli 16 and is rapidly titratable due to its unique pharmacokinetic properties. It has a context sensitive half-life of three minutes which is independent of the duration of infusion 17 . This rapid predictable offset of action facilitates early awakening and tracheal extubation.
TIVA with propofol and remifentanil therefore potentially offered desirable effects in this patient. The synergistic effect of the two agents allowed a reduction in propofol dose (target 0.7-2.8 µg/ml) thus improving haemodynamic stability, and the rapid predictable offset of action facilitated early recovery and tracheal extubation.
Limited experience exists with the use of propofol/ remifentanil TIVA in patients with severely impaired left ventricular function. Favourable results in a series of such patients undergoing insertion of cardioverter defibrillators has been reported 15 . A major concern in using this technique is the possibility of awareness. The BIS is a variable derived from the cortical electroencephalogram, shown to correlate with measures of drug-induced sedation and hypnosis 1 . BIS values generally range from 90 to 100 in the awake patient and 40 to 60 in the anaesthetized patient. Intraoperative use of BIS monitoring to titrate propofol dose has been shown to significantly reduce propofol infusion rates, time to eye-opening and tracheal extubation 2 . In our case, BIS monitoring similarly allowed safe titration and dose reduction of propofol, improving haemodynamic stability and allowing early tracheal extubation.
In conclusion this case describes the safe and effective use of propofol TCI and remifentanil in a patient with severely impaired left ventricular function undergoing thoracotomy and lobectomy. It highlights the value of BIS monitoring in allowing careful titration and reduction of propofol dose in such patients, thus improving haemodynamic stability and facilitating faster recovery while minimizing risk of awareness.
